BIOXCEL THERAPEUTICS INC. - COMMON STOCK
1.1150
08-July-24 14:22:23
15 minutes delayed
Stocks
+0.0650
+6.19%
Today's range
1.0600 - 1.1899
ISIN
N/A
Source
NASDAQ
-
06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14, 2023
31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
30 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
25 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
10 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
14 Aug 2023 07:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Second Quarter 2023 Financial Results on August 14, 2023
31 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
29 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Participate at Two Upcoming Investor Conferences
01 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
08 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at the BofA Securities 2023 Health Care Conference
02 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report First Quarter 2023 Financial Results on May 8, 2023
24 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
14 Mar 2023 16:15:08 By Nasdaq GlobeNewswire
-
09 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
23 Feb 2023 07:00:02 By Nasdaq GlobeNewswire